| Product Specialist |
Tamil Nadu |
Indien |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Sr. Spec. DDIT IES O365 Sec. & Compl. |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Global Category Manager, Clinical |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Beschaffung |
09. Oktober 2024 |
| Senior Specialist DDIT ISC Detection & Response |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Associate Director of Forensics |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Manager, Digital Finance |
Hyderabad (Office) |
Indien |
Finance |
Innovative Medicines |
Audit und Finanzen |
09. Oktober 2024 |
| Associate Director DDIT ISC Detection & Response |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Sr. Specialist DDIT ISC Detection & Response |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Global R2R PEC Automation Expert |
Hyderabad (Office) |
Indien |
Finance |
CTS |
Audit und Finanzen |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Senior Process Expert (m/f/d) - Temporary |
Schaftenau |
Österreich |
Operations |
Innovative Medicines |
Technical Operations |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
Operations |
Innovative Medicines |
Others |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Sales Value Associate Privado - Guadalajara |
INSURGENTES |
Mexiko |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Yibin (Sichuan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Technical Product Manager: Finance, Cloud Analytics |
Barcelona Gran Vía |
Spanien |
Operations |
CTS |
Technology Transformation |
09. Oktober 2024 |
| Clinical Operations Specialist |
Prague |
Tschechische Republik |
Operations |
CTS |
Research & Development |
09. Oktober 2024 |
| LDC Core Enablement Business and IT Controls |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Audit und Finanzen |
09. Oktober 2024 |
| （高级）医药代表 /（资深）产品专员 |
Guiyang (Guizhou Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
09. Oktober 2024 |
| Rare Disease Lead |
Serbia |
Serbien |
International |
Innovative Medicines |
Market Access |
09. Oktober 2024 |
| Senior Consultant – M&A Post-merger Integrations | Separations |
Prague |
Tschechische Republik |
Operations |
CTS |
BD&L & Strategic Planning |
09. Oktober 2024 |
| Postdoc Patient-Centered Outcomes |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Others |
09. Oktober 2024 |
| Lead Consultant – M&A Post-merger Integrations | Separations |
Prague |
Tschechische Republik |
Operations |
CTS |
BD&L & Strategic Planning |
09. Oktober 2024 |
| Medical Affairs Lead Specialty |
Warsaw |
Polen |
International |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |